Fast diabetes tests at your Doctor's office could save kidneys

NCT ID NCT06684990

Ongoing Knowledge-focused Sponsor: Taichung Veterans General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether using a fast point-of-care device to measure blood sugar control (HbA1c) and kidney function (cystatin C) during a clinic visit can improve long-term health in people with diabetes. Researchers will track changes in kidney function over time in 222 adults. The goal is to see if immediate results help doctors make better treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: point-of-care testing for HbA1c and cystatin C
What this could lead to: If successful, this could show that fast, in-clinic testing helps doctors manage diabetes better and slow kidney decline.
What could go wrong: This is an observational study without a control group, so results may not prove cause and effect. The benefit depends on how doctors use the test results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES

Contacts and locations

Locations

Taichung Veterans General Hospital

Taichung, 407219, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.